Data Rights Have Become a Bottleneck in Intelligent Traditional Chinese Medicine Manufacturing

The push toward digital and intelligent manufacturing in traditional Chinese medicine is running into a problem that is less visible than equipment failure and far more disruptive: the protection of source contributors’ rights over data assets. In this analysis, Chen and Zhang focus on a structural weakness in the data supply chain. When the people who generate high-value technical knowledge cannot see how ownership, attribution, or benefit-sharing will be handled, the supply of quality data becomes fragile. In a sector that depends on the capture of processing techniques, tacit knowledge, and operational know-how, weak rights protection can quickly become a brake on scale, trust, and reproducibility.

The paper frames the issue through information economics and algorithmic theory, arguing that the digitalization of TCM processing creates new vulnerabilities at two levels. First, physical control over technical knowledge becomes harder once expertise is externalized into data systems. Second, algorithmic complexity can obscure how data are used, transformed, or repurposed. In practical terms, the move from hands-on craft to machine-readable process data can make it easier to disseminate knowledge and harder to contain misappropriation. For industries built on accumulated expertise, that tension is not abstract. It directly shapes whether contributors remain willing to participate.

A single unresolved rights dispute can chill the flow of high-quality data.

Why Physical Custody No Longer Guarantees Control

The central risk mechanism described in the analysis is the failure of traditional physical control once technical knowledge is turned into digital input, training data, or model parameters. In a conventional manufacturing environment, access to the process itself may be limited by location, personnel, and equipment. Once those same procedures are abstracted into digital assets, however, a copied dataset or model can circulate far beyond the original setting. The work characterizes this shift as a breakdown in source protection: the original contributor may lose practical control even when the knowledge originated from that contributor’s labor and expertise.

The paper also points to institutional safeguards that can weaken when algorithms operate as black boxes. If users cannot easily determine how a model was trained, which data contributed to it, or whether outputs were derived from protected inputs, accountability becomes difficult to enforce. In a data-intensive manufacturing setting, that opacity can undermine trust in the entire system. The result is not only a legal problem but an economic one, because reduced trust can suppress the willingness to share high-quality data in the first place.

The analysis connects this chain of events to a deeper supply-side issue: without credible protection, the market for data contributions becomes underprovided. Contributors may be reluctant to release valuable process knowledge if they believe it can be extracted without recognition or compensation. For intelligent manufacturing in TCM, where quality depends heavily on specialized know-how, that reluctance can leave datasets incomplete, uneven, or biased toward lower-value material that is easier to share.

A Full-Cycle Safeguarding Model Combines Law and Technology

To address these vulnerabilities, the paper proposes a full-cycle safeguarding system built from both institutional and technological measures. Rather than relying on a single layer of protection, the framework links ownership clarification, traceability, and detection tools across the data lifecycle. The institutional component centers on data intellectual property registration, which is presented as a way to clarify ownership and support benefit-sharing. By making rights more legible, registration may reduce ambiguity around who created the data, who can use it, and how value should return to the source contributor.

This is a meaningful shift because rights protection in digital manufacturing cannot depend on informal recognition alone. Once data enter model-building pipelines, attribution becomes harder to reconstruct. Registration creates a documentary trail before that erasure occurs. In a sector where the value of process knowledge is often embedded in small differences in timing, temperature, sequence, and handling, documenting provenance can preserve the economic identity of the data even after technical transformation.

The technological layer is equally specific. The analysis identifies digital watermarking in the transformation domain and model backdoor detection as key tools for improving traceability and detecting misuse. Watermarking can embed identifying markers into data or transformed outputs so provenance remains detectable even after processing. Backdoor detection serves a different role: it looks for hidden manipulations or malicious triggers inside models that may threaten integrity or reveal unauthorized use. Together, these measures aim to make theft, copying, and covert misuse harder to hide.

Traceability Is the Practical Test of Rights Protection

In digital manufacturing, rights protection is only as strong as the system’s ability to trace an asset after it has been transformed. A contributor cannot benefit from ownership if ownership disappears the moment data are normalized, compressed, or absorbed into a model. The article’s core argument is that traceability must be designed into the process rather than added after a dispute surfaces. That is why the proposed framework links legal registration with technical watermarking and detection methods instead of treating them as separate fixes.

The same logic applies to benefit-sharing. If a contributor’s data help generate a productive algorithm, but that contribution cannot be verified, compensation becomes uncertain and confidence declines. A traceable system gives manufacturers a way to show where value came from and gives contributors a reason to keep supplying high-quality material. In that sense, the framework is not only about defense against misuse. It is also about creating a functioning incentive structure for future data production.

There is a wider industrial implication here. Intelligent manufacturing in TCM depends on repeated accumulation of reliable data, and reliable data depend on trust. When contributors believe that institutional safeguards are weak and algorithmic systems are opaque, they may hold back the very inputs that would improve quality and scale. The paper positions source protection as a prerequisite for the sustainable development of this sector, not a peripheral administrative concern.

Sustainable Growth Depends on Credible Incentives for Data Supply

The article closes with a broader policy vision: source protection may activate the endogenous motivation for data supply and support the high-quality development of intelligent TCM manufacturing. That formulation matters because it treats data governance as an industrial input, not merely a compliance issue. If contributor rights are clarified, traceability is strengthened, and misuse can be detected, the supply side becomes more willing to participate. If those conditions are absent, the system risks stagnation even if the technology itself is advanced.

For policymakers and industry stakeholders, the implication is straightforward. Digital transformation in TCM will not succeed on software alone. It requires a governance architecture capable of preserving ownership, documenting provenance, and deterring covert appropriation across the full data lifecycle. The article does not claim that any single measure will solve the problem on its own, and it leaves open how these tools will perform across different operational settings. The challenge now is whether registration systems, watermarking methods, and model integrity checks can be aligned closely enough to protect contributors without slowing the flow of innovation.


Reporting by Dr. Sarah Lin, MD, MPH for Medicine World Foundation, with additional data provided by Becker's Hospital Review.